"fax: (801) 773-4776"

During the past decade, Wasatch Peak Family Practice conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wasatch Peak Family Practice" #1 collaborator was "Galapagos NV" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wasatch Peak Family Practice" are "Non-Alcoholic Fatty Liver Disease" (2 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials) and "Sjogren's Syndrome" (1 trials). Many other conditions were trialed in "Wasatch Peak Family Practice" in a lesser frequency.

Most popular intervention types in "Wasatch Peak Family Practice" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Resmetirom" (2 trials), "Filgotinib" (1 trials), "Filgotinib placebo" (1 trials) and "Lanraplenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wasatch Peak Family Practice" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Wasatch Peak Family Practice". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wasatch Peak Family Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wasatch Peak Family Practice, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".